Decisional capacity determination and serious mental illness in oncology: Implications for equitable and beneficent care. Issue 12 (12th September 2021)

• Record Type: Journal Article
• Authors: McFarland, Daniel C.; Voigt, Louis; Alici, Yesne
• Other Names: Grassi Luigi guestEditor.; Riba Michelle guestEditor.
• Is Part Of: Psycho-oncology. Volume 30:Issue 12(2021)
• Page Start: 2052
• Page End: 2059
• Publication Date: 2021-09-12
• Subjects: cancer -- decisional capacity -- ethics -- oncology -- serious mental illness; Cancer -- Psychological aspects -- Periodicals; Cancer -- Social aspects -- Periodicals; Neoplasms -- psychology -- Periodicals; 616.9940019
• DOI: 10.1002/pon.5812
• Languages: English
• ISSNs: 1057-9249

Abstract

Abstract: Background: Patients with Serious Mental Illness (SMI) have worse survival compared to cancer patients without SMI after controlling for delayed diagnosis. Decision‐making capacity (DMC) may be impaired in both populations (cancer or SMI). DMC may be further impaired based on coupled vulnerability factors that challenge Shared Decision Making (SDM) for patients with cancer and SMI. Methods: Psychiatric consultations for DMC in hospitalized patients with cancer ( n = 97) were consecutively evaluated across a single institution cancer center. SMI data, demographic, and cancer‐related variables were obtained from the medical record. Descriptive data were contrasted in patients with and without DMC and used for logistic regression modeling. Results: Overall, 42% had DMC with no significant differences based on SMI ( χ 2 = 2.60, p = 0.11). Patients with SMI were younger, receiving anticancer treatment, and were less likely facing end of life issues. Age (OR 1.03, p = 0.05) and no recent anticancer treatments (OR 0.34, p = 0.02) were associated with decisional incapacity. At 3 months post discharge, almost two‐thirds were dead with no difference based on SMI ( χ 2 = 0.01, p = 0.91). But End of Life (EOL) concerns were documented in 63% of non‐SMI patients and only 36% of SMI patients ( χ 2 = 5.63, p = 0.02). Healthcare proxy (16%), four determinates of DMC (22%), and repeated psychiatric DCM assessments (35%) were documented with no differences based on SMI. Conclusion: SDM is not equitable for cancer patients with SMI. Advanced directives and a robust effort to provide value‐congruent care for patient with SMI who develop cancer may lessen this health inequity for cancer patients with SMI.